tiprankstipranks
Trending News
More News >
Rapport Therapeutics, Inc. (RAPP)
NASDAQ:RAPP
US Market
Advertisement

Rapport Therapeutics, Inc. (RAPP) Stock News & Sentiment

Compare
42 Followers
Premium
Ratings
Buy Rating for Rapport Therapeutics Driven by Upcoming Trial Milestone and Strong Pipeline Potential
2d ago
Premium
Company Announcements
Rapport Therapeutics Reports Q2 2025 Financials and Progress
8d ago
Premium
Company Announcements
Rapport Therapeutics Reports Q2 Results and Updates
9d ago
Premium
Ratings
Buy Rating for Rapport Therapeutics, Inc. Driven by Promising Phase IIa Trial and RAP Technology Potential
9d ago
Premium
Ratings
Buy Rating for Rapport Therapeutics: RAP-219’s Promising Potential in Epilepsy Treatment
9d ago
Premium
Company Announcements
Rapport Therapeutics Elects New Directors at Annual Meeting
2M ago
Premium
Company Announcements
Rapport Therapeutics Completes Enrollment for Phase 2a Trial
2M ago
More RAPP News >

News Score - Last 7 Days

Neutral
RAPP
Sector Average
Media Buzz
This Week2 articles
Weekly Average1.25 articles
News Sentiment
This Week59%
Sector Average63%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is RAPP’s Media Buzz Sentiment?
2 articles about RAPP were published this week. In an average week, 1.25 articles are published.
    What is RAPP’s weekly average amount of articles?
    In an average week, 1.25 articles about RAPP are published.
      What is RAPP’s News Sentiment?
      59% of articles about RAPP were positive this week, compared to its sector average of 63%.
        General Stocks that are Trending in the News
        FIL-USDFileCoin
        LINK-USDChainLink
        NEAR-USDNEAR Protocol
        ATOM-USDCosmos
        Showing the stocks with the most bullish news sentiment over the past week
        What am I Missing?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis